UK Appeal Panel Tells NICE To Revisit Scenesse Rejection

 
• By Ian Schofield
  
Think again!
NICE is to reconsider its recommendation on Clinuvel's Scenesse. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access